You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 10,912,814


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,912,814 protect, and when does it expire?

Patent 10,912,814 protects VOSEVI and is included in one NDA.

This patent has sixteen patent family members in sixteen countries.

Summary for Patent: 10,912,814
Title:Combination formulation of three antiviral compounds
Abstract: Disclosed are pharmaceutical compositions comprising three antiviral compounds. In particular, the pharmaceutical compositions comprise an effective amount of velpatasvir, an effective amount of sofosbuvir, and an effective amount of voxilaprevir. Also disclosed are methods of use for the pharmaceutical composition.
Inventor(s): Chal; Ben (Millbrae, CA), Nejati; Elham (San Mateo, CA), Pakdaman; Rowchanak (San Carlos, CA), Stefanidis; Dimitrios (Saratoga, CA)
Assignee: Gilead Pharmasset LLC (Foster City, CA)
Application Number:15/611,603
Patent Claim Types:
see list of patent claims
Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,912,814: A Detailed Analysis

Introduction

Patent 10,912,814, like any other patent, is a complex document that outlines the invention, its claims, and the scope of protection it receives. To analyze this patent, it is crucial to delve into its various components, including the background, summary, detailed description, and most importantly, the claims.

Background of the Patent

Before diving into the specifics of Patent 10,912,814, it is essential to understand the context in which it was filed. This includes the technological field it pertains to, the problems it aims to solve, and any relevant prior art.

Summary of the Invention

The summary section provides a brief overview of the invention. Here, you would typically find a concise description of what the invention is, its key features, and how it operates. This section sets the stage for the more detailed description that follows.

Detailed Description of the Invention

This section is where the inventors provide a thorough explanation of the invention, including its components, how it works, and any specific embodiments. It often includes diagrams, flowcharts, and detailed technical descriptions to help understand the invention fully.

Claims

The claims section is the most critical part of any patent, as it defines the scope of protection granted to the inventor. Here, we will analyze the claims in detail.

Independent Claims

Independent claims stand alone and do not rely on other claims. They define the broadest scope of the invention and are typically the most important claims in the patent.

Dependent Claims

Dependent claims build upon independent claims and add additional limitations. These claims are narrower in scope but can provide additional protection by specifying particular embodiments or features of the invention.

Claim Analysis

To analyze the claims of Patent 10,912,814, we need to consider several key aspects:

Subject Matter Eligibility

Given the recent updates from the USPTO, such as the 2024 guidance on AI patent eligibility, it is crucial to assess whether the claims integrate judicial exceptions into practical applications. This involves evaluating if the claims impose meaningful limits on the exceptions, transforming them into patent-eligible subject matter[1].

Practical Applications

Claims must demonstrate real-world applications that provide concrete benefits or solve specific problems in the relevant field. For example, if the patent involves AI technology, the claims should specify how the AI is used in a practical application, such as improving speech recognition systems, to ensure patent eligibility[1].

Inventive Concept

The claims must include an inventive concept that goes beyond routine data processing or mere abstract ideas. This means the claims should specify additional steps or elements that transform the abstract idea into a patent-eligible invention[1].

Examples from Similar Patents

To better understand how claims are crafted to meet patent eligibility criteria, let's consider an example from the 2024 USPTO guidance update. In this example, Claim 1 might involve routine data processing steps without any practical application, while Claim 2 specifies the use of separated audio components in a real-time speech recognition system to enhance voice command accuracy. Claim 2 is considered patent-eligible because it integrates the abstract idea into a practical application, providing tangible benefits such as improved noise reduction and accuracy in speech recognition[1].

Patent Landscape

Understanding the patent landscape involves looking at prior art, related patents, and the overall technological environment.

Prior Art Search

Conducting a thorough prior art search using tools like the USPTO's Patent Public Search, Global Dossier, and other international patent databases is essential. This helps in identifying existing patents and published applications that may be relevant to the invention[4].

Related Patents

Analyzing related patents can provide insights into how similar inventions have been claimed and the scope of protection they have received. This can help in drafting claims that are more likely to be approved.

Impact of Recent USPTO Guidance

The 2024 USPTO guidance update on AI patent eligibility has significant implications for innovators and patent practitioners. Here are some key points:

AI-Assisted Inventions

The update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Incorporation of Recent Case Law

The guidance incorporates recent case law to provide more clarity on what constitutes a patent-eligible claim. This includes examples of claims that integrate judicial exceptions into practical applications, making them eligible for patent protection[1].

Practical Applications and Real-World Benefits

To ensure patent eligibility, it is crucial to highlight the real-world applications and benefits of the claimed method or system. This involves demonstrating how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field.

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Practical Applications: Highlighting real-world applications and benefits is crucial for demonstrating patent eligibility.
  • Inventive Concept: Claims must include an inventive concept that goes beyond routine data processing or mere abstract ideas.
  • AI-Assisted Inventions: The use of AI in invention development does not impact subject matter eligibility.
  • Prior Art Search: Conducting thorough prior art searches is essential for understanding the patent landscape.

FAQs

Q: What is the significance of the 2024 USPTO guidance update on AI patent eligibility? A: The update refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing more tools for practitioners to evaluate patentability and draft eligible claims.

Q: How do practical applications impact patent eligibility? A: Practical applications are crucial as they demonstrate how an abstract idea is applied in a way that provides concrete benefits or solves specific problems, making the claim patent-eligible.

Q: Can AI-assisted inventions be patented? A: Yes, AI-assisted inventions are evaluated on equal footing with other technologies. The focus remains on the claimed invention itself, not the method of invention development.

Q: What is the role of prior art search in patent analysis? A: Prior art search helps identify existing patents and published applications relevant to the invention, ensuring that the claims are novel and non-obvious.

Q: How do dependent claims differ from independent claims? A: Dependent claims build upon independent claims and add additional limitations, providing narrower but more specific protection.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz.
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov.
  3. Patent Claims Research Dataset - USPTO.
  4. Search for patents - USPTO.
  5. Report on Filing Patent/Trademark - United States Courts.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,912,814

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gilead Sciences Inc VOSEVI sofosbuvir; velpatasvir; voxilaprevir TABLET;ORAL 209195-001 Jul 18, 2017 RX Yes Yes 10,912,814 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.